Immunovant Inc — Cash Flow (NASDAQ:IMVT) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 83.33 M106.11 M188.19 M214.23 M375.87 M 422.89 M Cash from investing activities 210 K254 K197 K360 K759 K 201 K Cash from financing activities 383.11 M200.13 M70.89 M472.43 M454.49 M 1.04 B Free cash flow 83.12 M105.86 M188 M213.87 M375.12 M 422.69 M

新闻

Immunovant stock hits 52-week high at 28.32 USD

Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?

Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?

Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?

IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus

Immunovant股票创历史新高达27.87美元

Immunovant stock hits all-time high at 27.87 USD

Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript

Immunovant股价跳涨7%，第三季度亏损收窄，优于预期

Immunovant shares jump 7% as Q3 loss narrows, beats estimates

Philip Morris, Biogen, Telenor, and more set to report earnings Friday

Immunovant earnings up next as Graves’ disease optimism builds